Patients

EM Imaging  is focused on fluorescent optical imaging agents. Our current clinical trials are listed below.

EMI-200: Lung Neutrophil Imaging (UK)

Title: Phase 1 Dose Escalation and Imaging EMI-200 topically administered to the lungs of  Adult Subjects With Inflammation
Objective: Evaluate the clinical safety and efficacy of  EMI-200 in patients with lung inflammation
Status: Enrolment ongoing
More information: contact at info@edinimage.com

EMI-137: IMAGING OF BREAST CANCER AND ORAL DURING SURGERY (UK)

Title: A pilot study of GE-137 fluorescence imaging to improve the accuracy of surgical excision in patients with primary breast cancer or oral cancer
Objective: The aim of this phase I/II study is to assess the feasibility of GE-137 fluorescence imaging for intra-operative assessment of tumour margin status and lymph node metastatic status in breast cancer and oral squamous cell carcinoma (OSCC) patients
Status: Enrolment ongoing
More information: please contact info@edinimage.com

adminPatients